Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Is polymyositis or dermatomyositis in patients with rheumatoid arthritis induced or unveiled by anti-tumor necrosis factor treatment?

Is polymyositis or dermatomyositis in patients with rheumatoid arthritis induced or unveiled by... Clin Rheumatol (2010) 29:819–820 DOI 10.1007/s10067-010-1467-6 LETTER TO EDITOR Is polymyositis or dermatomyositis in patients with rheumatoid arthritis induced or unveiled by anti-tumor necrosis factor treatment? Takao Nagashima & Seiji Minota Received: 6 April 2010 /Accepted: 7 April 2010 /Published online: 20 April 2010 Clinical Rheumatology 2010 Dear Editor, misdiagnosed as RA. Overlap of ASS and classical RA can We read the recent article by Ishikawa et al. [1] “Etanercept- also occur [4]. If such patients are treated for RA with TNF induced anti-Jo-1-antibody-positive polymyositis in a patient antagonists and subsequently develop myositis, it becomes with rheumatoid arthritis: a case report and review of the difficult to decide whether this has been induced by the TNF literature” with great interest. We would like to make some antagonist or is related to ASS. comments about the development of myositis in relation to They also speculated that patients with some background anti-tumor necrosis factor (TNF) therapy. risks (positivity for antinuclear antibody (ANA) or anti-Jo-1 An association of polymyositis (PM)/dermatomyositis antibodies) tend to develop autoimmune phenomena during (DM) with rheumatoid arthritis (RA) has long been well- therapy with TNF antagonists [1]. Anti-TNF therapy has been known [2]. We recently reported two RA http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Clinical Rheumatology Springer Journals

Is polymyositis or dermatomyositis in patients with rheumatoid arthritis induced or unveiled by anti-tumor necrosis factor treatment?

Clinical Rheumatology , Volume 29 (7) – Apr 20, 2010

Loading next page...
 
/lp/springer-journals/is-polymyositis-or-dermatomyositis-in-patients-with-rheumatoid-Pq8kXrNcVC

References (11)

Publisher
Springer Journals
Copyright
Copyright © 2010 by Clinical Rheumatology
Subject
Medicine & Public Health; Rheumatology
ISSN
0770-3198
eISSN
1434-9949
DOI
10.1007/s10067-010-1467-6
pmid
20405301
Publisher site
See Article on Publisher Site

Abstract

Clin Rheumatol (2010) 29:819–820 DOI 10.1007/s10067-010-1467-6 LETTER TO EDITOR Is polymyositis or dermatomyositis in patients with rheumatoid arthritis induced or unveiled by anti-tumor necrosis factor treatment? Takao Nagashima & Seiji Minota Received: 6 April 2010 /Accepted: 7 April 2010 /Published online: 20 April 2010 Clinical Rheumatology 2010 Dear Editor, misdiagnosed as RA. Overlap of ASS and classical RA can We read the recent article by Ishikawa et al. [1] “Etanercept- also occur [4]. If such patients are treated for RA with TNF induced anti-Jo-1-antibody-positive polymyositis in a patient antagonists and subsequently develop myositis, it becomes with rheumatoid arthritis: a case report and review of the difficult to decide whether this has been induced by the TNF literature” with great interest. We would like to make some antagonist or is related to ASS. comments about the development of myositis in relation to They also speculated that patients with some background anti-tumor necrosis factor (TNF) therapy. risks (positivity for antinuclear antibody (ANA) or anti-Jo-1 An association of polymyositis (PM)/dermatomyositis antibodies) tend to develop autoimmune phenomena during (DM) with rheumatoid arthritis (RA) has long been well- therapy with TNF antagonists [1]. Anti-TNF therapy has been known [2]. We recently reported two RA

Journal

Clinical RheumatologySpringer Journals

Published: Apr 20, 2010

There are no references for this article.